High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis

Table 1

Baseline patient characteristics after matching.

	Brachytherapy ()	HIFU ()	value
Median age (IQR; SD), years	69 (54–79; 6.5)	74 (62–86; 4.47)	<0.01
Clinical stage (T)			0.54
T1a	1	2
T1b	2	6
T1c	38	31
T2a	20	19
T2b	9	12
Gleason score			1
≤6	51	51
7	19	19
PSA (ng/mL)			0.23
≤10	57	50
>10 et ≤20	13	20
D’Amico risk classification			0.33
Low	33	31
Intermediate	37	39
Neoadjuvant ADT	14	19	0.43
ASA score			0.68
1	8	10
2	47	42
3	15	18
Median follow-up (IQR), months	44 (21–70)	83 (29–98)	<0.01